Recombinant protein TRAIL-Mu3 enhances the antitumor effects in pancreatic cancer cells by strengthening the apoptotic signaling pathway

Pancreatic cancer is a highly malignant type of cancer and its treatment remains a major challenge. The novel recombinant protein TNF-related apoptosis-inducing ligand (TRAIL)-Mu3 has been shown to exert stronger tumor inhibitory effects in colon cancer in vitro and in vivo compared with TRAIL. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Min, Yi, Cheng, Huang, Xian-Zhou, Yan, Juan, Wei, Li-Jia, Tang, Wei-Ju, Chen, Shou-Chun, Huang, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045166/
https://www.ncbi.nlm.nih.gov/pubmed/33868476
http://dx.doi.org/10.3892/ol.2021.12699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045166/
https://www.ncbi.nlm.nih.gov/pubmed/33868476
http://dx.doi.org/10.3892/ol.2021.12699

Ejemplares similares